DESOXIMETASONE (desoximetasone) by Sandoz is signaling, immune function, inflammation and protein regulation; however, the precise mechanism of action in psoriasis is unknown. Approved for plaque psoriasis in patients 18 years of age, older (), older and 1 more indications. First approved in 2012.
Drug data last refreshed 18h ago
signaling, immune function, inflammation and protein regulation; however, the precise mechanism of action in psoriasis is unknown.
Worked on DESOXIMETASONE at Sandoz? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.